Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Pharmacology and safety of tetradecylthioacetic acid (TTA): phase-1 study.

Pettersen RJ, Salem M, Skorve J, Ulvik RJ, Berge RK, Nordrehaug JE.

J Cardiovasc Pharmacol. 2008 Apr;51(4):410-7. doi: 10.1097/FJC.0b013e3181673be0.

PMID:
18427285
3.

The absorption, distribution and biological effects of a modified fatty acid in its free form and as an ethyl ester in rats.

Gudbrandsen OA, Wergedahl H, Bohov P, Berge RK.

Chem Biol Interact. 2009 May 15;179(2-3):227-32. doi: 10.1016/j.cbi.2008.10.004. Epub 2008 Oct 15.

PMID:
18992229
4.

Pharmacokinetics of 8-hour intravenous infusion of NXY-059: a phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers.

Cheng YF, Jiang J, Hu P, Reinholdsson I, Guo W, Asenblad N, Nilsson D.

Clin Ther. 2008 Dec;30(12):2342-53. doi: 10.1016/j.clinthera.2008.12.013.

PMID:
19167593
5.

Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.

Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ.

Clin Ther. 2008 Oct;30(10):1817-30. doi: 10.1016/j.clinthera.2008.10.013.

PMID:
19014837
6.
7.
8.

Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies.

Darwish M, Kirby M, Hellriegel ET, Yang R, Robertson P Jr.

Clin Drug Investig. 2009;29(2):87-100. doi: 10.2165/0044011-200929020-00003.

PMID:
19133704
9.
11.
12.

Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.

Zhao RK, Cheng G, Tang J, Song J, Peng WX.

Clin Ther. 2009 May;31(5):1022-36. doi: 10.1016/j.clinthera.2009.05.005.

PMID:
19539103
14.

Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.

Poo JL, Galán JF, Rosete A, de Lago A, Oliva I, González-de la Parra M, Jiménez P, Burke-Fraga V, Namur S.

Clin Ther. 2008 Apr;30(4):693-9.

PMID:
18498918
15.
16.

Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study.

Chu NN, Chen WL, Xu HR, Li XN.

Clin Drug Investig. 2009;29(7):451-7. doi: 10.2165/00044011-200929070-00003.

PMID:
19499962
17.

Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.

Algorta J, Pena MA, Alvarez A, Maraschiello C, Maruhn D, Windisch M, Mucke HA.

Int J Clin Pharmacol Ther. 2009 Jul;47(7):483-90.

PMID:
19640356
18.

Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.

Kalaiarasi P, Kaviarasan K, Pugalendi KV.

Eur J Pharmacol. 2009 Jun 10;612(1-3):93-7. doi: 10.1016/j.ejphar.2009.04.003. Epub 2009 Apr 8.

PMID:
19361497
19.

Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects.

Chandra KP, Shiwalkar A, Kotecha J, Thakkar P, Srivastava A, Chauthaiwale V, Sharma SK, Cross MR, Dutt C.

Clin Drug Investig. 2009;29(9):559-75. doi: 10.2165/11315260-000000000-00000.

PMID:
19663519
20.

Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.

Kim BH, Yi S, Kim J, Lim KS, Kim KP, Lee B, Shin SG, Jang IJ, Yu KS.

Clin Ther. 2009 Jun;31(6):1234-43. doi: 10.1016/j.clinthera.2009.06.008.

PMID:
19695390

Supplemental Content

Support Center